NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 3 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Vinati Organics Announces ₹500 Cr Capex, Reports Consolidated Q2 FY27 PAT Down 15% to ₹187 Cr
In its Q2 FY2027 earnings call transcript, Vinati Organics reported consolidated net income growth of 23% YoY to ₹693 crore, while EBITDA declined 24% YoY to ₹138 crore and PAT fell 15% YoY to ₹187 crore due to unabsorbed energy and logistics cost spikes. The company announced a ₹500 crore internal-accrual-funded capex to develop new specialty chemicals over two years, plus an additional ₹500 crore capex currently in land acquisition stages. Revenue for FY2027 is guided to grow 20%-25% YoY, supported by anticipated H2 volume recoveries in ATBS and Butyl Phenol segments. VOPL revenue expectation for the year was revised to ₹75-100 crore due to internal process re-engineering, which will delay full streamlining until April/May next fiscal year.
உச்சம் நம்பிக்கை
என்ன மாறியதுVinati Organics disclosed its Q2 FY2027 earnings transcript, revealing margin compression alongside an announced ₹500 crore specialty chemicals capex.
ஏன் இது முக்கியம்The company's profitability is being squeezed by elevated logistics and energy costs that cannot be passed through immediately, though substantial internal capex shows continued long-term expansion.
📅 குறுகிய காலம்Margins will remain under scrutiny as investors look for expected freight and energy cost reductions to flow into Q3 and Q4 results.
📈 நீண்ட காலம்The ₹500 crore planned capex (plus ₹500 crore pipeline) and expanding antioxidant/ATBS capacities reinforce long-term specialty chemicals market positioning once demand destocking stabilizes.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical disruptions inflating freight and energy prices
Customer destocking slowing ATBS demand pickup
Internal process re-engineering delays in subsidiary VOPL
👀 கவனிக்க வேண்டியவை
Track the margin trajectory in Q3/Q4 FY2027 as freight rates cool, and monitor progress on VOPL process re-engineering targeted for completion by April 2027.
Vinati Organics Approves ₹500 Cr Greenfield Capex Plan Funded via Internal Accruals
Vinati Organics has approved an aggregate capital expenditure plan of ₹500 crore across the parent company and its wholly owned subsidiary, Veeral Organics Private Limited. The planned investment represents ~21% of TTM revenue (₹2,381 crore) and ~15.5% of net worth (₹3,216 crore). The greenfield projects will target new specialty chemicals catering to resins, fragrances & personal care, water treatment, and oil fields. The expansion is slated for commissioning within the next two years and will be financed entirely through internal accruals.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved a new ₹500 crore greenfield capital expenditure program spanning Vinati Organics and subsidiary Veeral Organics.
ஏன் இது முக்கியம்Adds revenue visibility and diversifies the portfolio into resins, fragrances, and personal care without leveraging the balance sheet.
Approved Capex: ₹500 CroreCapex vs TTM Revenue: ~21.0%Capex vs Net Worth: ~15.5%Commissioning Timeline: Within 2 yearsMode of Financing: Internal accruals
📅 குறுகிய காலம்Positive sentiment booster given company's net cash balance sheet and growth visibility, although earnings impact will only materialize in ~2 years.
📈 நீண்ட காலம்Enhances long-term growth and product diversification away from core ATBS and IBB, supporting the target of a 20% top-line CAGR.
⚠ அபாய எச்சரிக்கைகள்
Execution delays typical of greenfield chemical projects
Ramp-up and demand risk in new specialty chemical verticals
👀 கவனிக்க வேண்டியவை
Track quarterly project updates, environmental clearances, and civil construction progress across the next 24 months to gauge timely execution without cost overruns.
Vinati Organics Q2 Standalone PAT Falls 32.7% YoY to ₹86.84 Cr Despite 22.3% Revenue Rise
Vinati Organics reported standalone revenue from operations of ₹668.00 crore for Q2 FY27 (ended September 30, 2026), up 22.3% YoY from ₹546.27 crore, but down 4.3% QoQ from ₹697.75 crore. Standalone Profit After Tax (PAT) declined sharply by 32.7% YoY to ₹86.84 crore compared to ₹129.02 crore in Q2 FY26, driven by higher raw material costs of ₹424.22 crore (vs ₹254.89 crore YoY). For H1 FY27, revenue reached ₹1,365.75 crore with a net profit of ₹210.40 crore, while cash and cash equivalents remained low at ₹2.95 crore. The company maintains a zero-borrowing balance sheet with total equity standing at ₹3,337.39 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுVinati Organics released its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
ஏன் இது முக்கியம்Significant input cost inflation compressed operating margins, resulting in a over 32% decline in quarterly net profit despite top-line growth.
Standalone Revenue (Q2): ₹668.00 கோடிStandalone PAT (Q2): ₹86.84 கோடிCost of materials consumed (Q2): ₹424.22 கோடிStandalone Net Worth: ₹3,337.39 கோடிBasic EPS (Q2): ₹8.38
📅 குறுகிய காலம்Margins may remain under pressure until feedstock price increases are fully passed on to end customers, which may weigh on near-term sentiment.
📈 நீண்ட காலம்Long-term outlook is linked to the company's global leadership in ATBS (60-65% market share) and the execution of capacity additions in Antioxidants and VOPL product lines.
⚠ அபாய எச்சரிக்கைகள்
Sharp increase in raw material consumption costs depressing gross margins
Crude and derivative feedstock price volatility
Subdued QoQ revenue progression (-4.3%)
👀 கவனிக்க வேண்டியவை
Track management commentary on input cost inflation and pricing pass-through lag for key products like ATBS, alongside the commercial ramp-up timeline of subsidiary Veeral Organics (VOPL).
Vinati Organics Sets Sept 16, 2026 Record Date for Rs 8.50/Share Final Dividend
Vinati Organics has fixed September 16, 2026 as the record date to determine shareholder eligibility for a final dividend of Rs 8.50 per equity share (face value Re 1) for FY26. The 37th Annual General Meeting is scheduled for September 23, 2026 via video conferencing. Upon approval at the AGM, the dividend will be disbursed within 30 days of the meeting. The remote e-voting window will be open from September 18 to September 22, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுFormal intimation of AGM schedule and record date for the FY26 final dividend payout.
ஏன் இது முக்கியம்Confirms the cash distribution timeline to shareholders, delivering a steady payout backed by the company's zero-debt balance sheet.
Final dividend per share: Rs 8.50முக மதிப்பு: Re 1ரெக்கார்ட் தேதி: 16-செப்.-2026AGM date: 23-செப்.-2026
📅 குறுகிய காலம்Share price will adjust for the Rs 8.50 per share dividend on the ex-dividend date around mid-September 2026.
📈 நீண்ட காலம்Limited; this is a routine annual dividend payout consistent with the company's historical capital return profile.
👀 கவனிக்க வேண்டியவை
Investors seeking entitlement must hold shares before the ex-dividend date prior to September 16, 2026; track shareholder voting outcomes post-AGM on September 23, 2026.
Vinati Organics Q1 Revenue Grows 28.7% YoY to Rs 698 Cr; Standalone PAT Up 8.8%
Vinati Organics reported a strong top-line performance for Q1 FY27, with standalone revenue from operations rising 28.7% YoY to Rs 697.75 Cr. Standalone Net Profit grew at a more modest pace of 8.8% YoY to Rs 123.86 Cr, reflecting some margin pressure as total expenses surged 36% YoY. Sequentially, revenue grew 14.3% compared to the March 2026 quarter, indicating a continued recovery in volumes. The company maintained its debt-free status while delivering an EPS of Rs 11.92 for the quarter.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned into FY27 with significant double-digit revenue growth, moving past the flatter growth seen in FY25-26.
ஏன் இது முக்கியம்The strong revenue growth validates the company's strategy of expanding ATBS volumes and scaling new products like Antioxidants and MEHQ, although rising input costs are currently tempering bottom-line gains.
📅 குறுகிய காலம்The stock may see positive momentum due to the strong revenue beat, though the market will likely scrutinize the 36% jump in expenses which limited profit growth.
📈 நீண்ட காலம்The company's structural position as a global leader in ATBS (60-65% market share) and its diversification into Antioxidants and MEHQ support its 20% top-line CAGR target over the next 3 years.
⚠ அபாய எச்சரிக்கைகள்
Raw material cost inflation (up 28% YoY)
Margin compression (OPM at ~27% vs TTM 29.3%)
Geopolitical risks affecting feedstock supply
👀 கவனிக்க வேண்டியவை
Investors should monitor the operating profit margins (OPM) in upcoming quarters to see if the company can pass on rising raw material costs, which grew faster than revenue this quarter. Watch for the utilization levels of the new MEHQ and Guaiacol capacities which are expected to contribute to FY27 growth.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Vinati Organics Announces ₹8.50 Final Dividend and TDS Guidelines for FY 2025-26
Vinati Organics Limited has recommended a final dividend of ₹8.50 per equity share (850% of face value) for the financial year ended March 31, 2026. The company has issued a detailed communication regarding Tax Deduction at Source (TDS) requirements for various shareholder categories. Resident individuals are exempt from TDS if their total dividend from the company does not exceed ₹10,000, while others face a standard 10% or 20% deduction depending on PAN availability. Shareholders must submit necessary tax exemption documents by July 25, 2026.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹8.50 per equity share of face value ₹1 for FY 2025-26.Standard TDS rate of 10% for resident shareholders with a valid PAN and 20% for those without.No TDS for resident individuals if the aggregate dividend paid during the year is ₹10,000 or less.Non-resident shareholders can opt for Double Taxation Avoidance Agreement (DTAA) benefits by submitting required documents.The deadline for submission of tax-related documents and forms (like Form 15G/15H) is July 25, 2026.
👀 கவனிக்க வேண்டியவை
Shareholders should verify that their PAN and bank details are correctly registered and submit relevant tax exemption forms via the RTA portal before July 25, 2026, to ensure appropriate tax treatment.
Vinati Organics Invests ₹19.88 Crore in Subsidiary Veeral Organics via Rights Issue
Vinati Organics has infused ₹19.88 crore into its wholly-owned subsidiary, Veeral Organics Pvt. Ltd., by subscribing to 1.98 crore equity shares. This investment supports the subsidiary's growth in the organic fine specialty chemicals segment, which is highly aligned with the parent company's core business. Notably, Veeral Organics has shown rapid scaling, with turnover jumping from ₹0.09 crore in FY24 to ₹21.94 crore in FY26. The transaction maintains Vinati's 100% ownership and reflects a commitment to expanding its specialty chemical footprint.
முக்கிய அம்சங்கள்
Subscribed to 1,98,80,000 equity shares at a face value of ₹10 each, totaling ₹19.88 crore.Veeral Organics' turnover grew 108% year-on-year to ₹21.94 crore in FY26 from ₹10.55 crore in FY25.The subsidiary focuses on manufacturing Organic Fine Specialty Chemicals, ensuring business synergy.Investment was made via a rights issue and does not change the 100% ownership structure.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive sign of internal growth and scaling of the subsidiary's operations. Monitor the consolidated financial impact as Veeral Organics begins to contribute more significantly to the top line.
Vinati Organics FY26 PAT Grows 17.5% to ₹488 Cr; Final Dividend of ₹8.50 Declared
Vinati Organics reported a 17.5% YoY increase in full-year net profit to ₹487.78 crore, despite a slight 1.8% decline in annual revenue to ₹2,208.22 crore. The company's Q4 FY26 PAT rose to ₹137.51 crore from ₹127.57 crore in the year-ago period, driven by efficient cost management as total annual expenses fell by 6.4%. The board has recommended a final dividend of ₹8.50 per share (850% of face value). The company maintains a strong financial position with cash flow from operations reaching ₹628.42 crore for the fiscal year.
முக்கிய அம்சங்கள்
Annual Net Profit rose 17.5% to ₹487.78 Cr in FY26 vs ₹415.23 Cr in FY25.Q4 FY26 PAT increased to ₹137.51 Cr, up from ₹127.57 Cr in the same quarter last year.Board recommended a final dividend of ₹8.50 per equity share of face value ₹1.Annual revenue saw a marginal decline of 1.8% to ₹2,208.22 Cr compared to ₹2,248.10 Cr.Full-year Earnings Per Share (EPS) improved to ₹47.05 from ₹40.05 in the previous year.
👀 கவனிக்க வேண்டியவை
The results demonstrate strong operational efficiency and margin expansion despite a flat revenue environment. Long-term investors should find the consistent profit growth and healthy dividend payout encouraging for holding the stock.
Vinati Organics Invests ₹22.95 Crore in Subsidiary Veeral Organics
Vinati Organics Limited has infused ₹22.95 crore into its wholly-owned subsidiary, Veeral Organics Private Limited, through a rights issue. The investment involves subscribing to 2.29 crore equity shares at par value to support the subsidiary's specialty chemical manufacturing operations. Veeral Organics has shown significant operational scaling, with turnover rising from near zero in FY24 to ₹10.55 crore in FY25. This move strengthens the parent company's footprint in the organic fine specialty chemicals segment.
முக்கிய அம்சங்கள்
Additional investment of ₹22.95 crore through subscription of 2,29,50,000 equity shares.Subsidiary turnover grew from ₹0.09 crore in FY24 to ₹10.55 crore in FY25.Veeral Organics remains a 100% wholly-owned subsidiary after the transaction.Investment is aimed at expanding the manufacturing of Organic Fine Specialty Chemicals.
👀 கவனிக்க வேண்டியவை
Investors should track the revenue contribution of Veeral Organics in upcoming consolidated results as it scales from a pre-revenue stage. The rapid growth in subsidiary turnover is a positive lead indicator for the company's diversification strategy.
Vinati Organics Q3 PAT Rises 7.6% YoY to ₹100.8 Cr; Revenue Flat at ₹530.8 Cr
Vinati Organics reported a consolidated net profit of ₹100.83 crore for Q3 FY26, representing a 7.6% increase compared to ₹93.70 crore in the same quarter last year. Revenue from operations remained relatively stagnant at ₹530.78 crore, showing a marginal 1.7% YoY growth but a 3.5% sequential decline from Q2. For the nine-month period ended December 2025, PAT grew by 13.3% to ₹319.89 crore, while revenue growth was muted at 1.4%. The board also approved revisions to several corporate policies, including the Dividend Distribution and Related Party Transactions policies.
முக்கிய அம்சங்கள்
Consolidated Revenue for Q3 FY26 stood at ₹530.78 Cr, up 1.7% YoY but down 3.5% QoQ.Net Profit (PAT) for the quarter reached ₹100.83 Cr, a 7.6% increase YoY but a 12.2% drop from the previous quarter.9M FY26 PAT increased to ₹319.89 Cr from ₹282.21 Cr in the previous year period.Earnings Per Share (EPS) for Q3 FY26 was ₹9.73 compared to ₹9.04 in Q3 FY25.Board approved revisions to the Dividend Distribution Policy and Code of Conduct for Insider Trading.
👀 கவனிக்க வேண்டியவை
The results indicate stagnant top-line growth and a sequential decline in profitability, suggesting near-term headwinds in the chemical sector. Investors should maintain a watch on volume growth and management's guidance regarding the new policy revisions.
Vinati Organics Invests ₹31.19 Crore in Subsidiary Veeral Organics
Vinati Organics Limited has announced an additional investment of ₹31.19 Crore in its wholly-owned subsidiary, Veeral Organics Private Limited (VOPL). The company subscribed to 3,11,90,000 equity shares at a face value of ₹10 each through a rights issue. VOPL is engaged in manufacturing organic fine specialty chemicals, which is directly aligned with Vinati Organics' core business. This capital infusion is expected to support the subsidiary's growth and manufacturing capabilities.
முக்கிய அம்சங்கள்
Additional investment of ₹31.19 Crore in wholly-owned subsidiary Veeral OrganicsSubscription to 3,11,90,000 equity shares at par value of ₹10 eachVeeral Organics reported a turnover of ₹10.55 CroreMaintains 100% shareholding and control in the specialty chemicals entity
👀 கவனிக்க வேண்டியவை
Investors should monitor the capacity utilization and revenue contribution of Veeral Organics to the consolidated books. The investment signals the parent company's confidence in the subsidiary's specialty chemical projects.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
